Dolly Parton Partly Funded Moderna's COVID-19 Vaccine Research - Yes, Really!

Brenda Watkins
November 19, 2020

American singer-songwriter Dolly Parton had been involved in her first vehicle accident and although she wasn't badly injured, she paid a visit to the Vanderbilt University Medical Centre.

Music icon Dolly Parton has been revealed to be one of the major funders of Moderna's coronavirus vaccine, which is said to be almost 95 percent effective, according to early data.

On Monday, Moderna announced that its vaccine, developed under President Trump's Operation Warp Speed, turned out a 94.5% success rate in preventing the virus during large-scale human trials.

"I'm sure many millions of dollars from many people went into that", she told co-presenters Alex Jones and Jermaine Jenas as reported by BBC News website.

It was just announced this week that that experimental coronavirus vaccine is almost 95 percent effective at preventing illness.

It doesn't seem like Dolly Parton's fandom will stop growing any time soon. Unknown to her, part of it went to an early-stage trial of the Moderna vaccine, BBC reported yesterday, November 18.

She wrote: "My longtime friend Dr Naji Abumrad, who's been involved in research at Vanderbilt for many years, informed me that they were making some exciting advancements towards research of the coronavirus for a cure".

YouTube's new audio ads were designed for music and podcast fans
Payouts to users with monetized channels will now be "treated as royalties from a USA tax perspective", according to the update. Direct response advertisers have been flocking to YouTube during the pandemic as they struggle to keep their businesses afloat.

A preliminary report of the vaccine published in July in The New England Journal of Medicine includes it was supported by the "Dolly Parton COVID-19 Research Fund".

"Two of these antibodies are now being tested by a global pharmaceutical firm".

"What does Dolly Parton do when she's not delivering more than 100 million books to kids who need them?" asked Washington Post's Cathleen Decker.

Moderna is the second American drugmaker after Pfizer to report exciting vaccine results, raising hopes that the USA could have two vaccines authorised for emergency use in December.

These doses took place four weeks apart, and the analysis was based on the first 95 tested to develop COVID-19 symptoms.

The Cambridge, Massachusetts-based biotechnology company's vaccine is on the last legs of development and has proved to be almost 95% effective.

Other reports by

Discuss This Article